Using Hollywood CGI Technology to Create Perfect Protective Coverings

 

The latest Avengers blockbuster movie and the hugely popular Fortnite video game series both use powerful software to create spectacular graphics and CGI so lifelike your eyes think it’s real. But deploying similar technology to create protective coverings might be even more unexpected. On today’s podcast, Bob Coulter, director of data acquisitions & technology at Transhield, revealed how his company utilizes CGI software to create perfect-fitting protective covers.

The road that led Coulter to Transhield goes through Hollywood. Over two decades ago, he spent his time directing and producing commercials and music videos before transitioning into a career in game development. Later, he left media creation altogether and joined some old friends at Transhield where he said it was cool to see how different skillsets could be used in creative ways, in this case, to build protective coverings.

Leveraging his past experiences, he began working with the same software developed for media creation to model perfect fitted coverings.

“We’re probably one of the few people who utilize the software in this manner,” Coulter said.

The technology digitizes the process of modeling, so when a company sends over laser scans of an engine, Coulter’s team will use the software to design custom covers that can shield the engine from mildew, moisture, and microbials that lead to corrosion.

“There’s a huge percentage of our GDP that rots away in fields so protecting those assets is valuable,” Coulter said.

While his own background is unique, he mentioned that the company also employs fashion designers and expert package engineers who harness their special training to help in creating superior protective solutions.

From day one, Coulter said, he was “blown away by just how much talent was within Transhield.”

For the latest news, videos, and podcasts in the Transportation Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @TransportMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More